Clinical Support System for Serious Mental Illness Funding Opportunity Announcement (FOA)

Initial Announcement
Funding Opportunity Announcement (FOA) Information
FOA Number: 
SM-18-020
Posted on Grants.gov: 
Wednesday, January 17, 2018
Application Due Date: 
Monday, March 19, 2018
Catalog of Federal Domestic Assistance (CFDA) Number: 
93.243
Intergovernmental Review (E.O. 12372): 
Applicants must comply with E.O. 12372 if their state(s) participates. Review process recommendations from the State Single Point of Contact (SPOC) are due no later than 60 days after application deadline.
Public Health System Impact Statement (PHSIS) / Single State Agency Coordination: 
Applicants must send the PHSIS to appropriate State and local health agencies by application deadline. Comments from Single State Agency are due no later than 60 days after application deadline.
Description

The Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Mental Health Services (CMHS) is accepting applications for fiscal year (FY) 2018 Clinical Support System for Serious Mental Illness (Short Title: CSS-SMI) grant. The purpose of this program is provide technical assistance (TA) for the implementation and provision of evidence-based treatment and recovery support programs for individuals living with serious mental illness (SMI). The program aims to establish a national Center to provide this TA to providers, programs and communities across the nation.

The program initiative will focus on the development and delivery of technical assistance that supports the implementation of evidence-based practices in the person- centered treatment and recovery support of individuals with SMI. The CSS-SMI is intended to target localities and populations, particularly those with SMI, who currently have limited access to good care that incorporates evidence-based practices. This is in alignment with the Interdepartmental SMI Coordinating Committee (ISMICC) recommendations that more people with SMI get good care and that there are fewer gaps in obtaining treatment and recovery support services for persons with SMI. The CSS-SMI is intended to have two particular clinical foci: 1. Promotion of the optimization of and increased access to the safe use of evidence-based and person-centered pharmacological interventions that are beneficial in the treatment of many persons with SMI, such as long-acting injectable antipsychotic medications and the use of clozapine and 2. Increased access and engagement so that more people with SMI are able to get good care. In this context, good care includes access to a range of person-centered services, such as crisis services, that are equipped to work with individuals with SMI. Good care also includes access to a set of recovery support services that are provided by professionals, including peer support specialists, who work together with psychiatric medical staff and over time to seamlessly coordinate and optimize person-centered recovery.  We are particularly interested in the promotion and implementation of optimal pharmacologic treatment and recovery support services in localities of greatest need. These components of the initiative focus on the education and training needs of service providers and implementation needs of programs providing services to those living with SMI.  Provision of information about best practices as they relate to prevention, treatment and recovery services for SMI oriented toward the needs of individuals living with these conditions and their families is also an important component of this initiative. Because this project requires a national focus that addresses all aspects of SMI, consortia of providers, academic programs, and other stakeholders are encouraged.  

CSS-SMI grants are authorized under Section 520A of the Public Health Service Act.

This announcement addresses Healthy People 2020 Mental Health and Mental Disorders Topic Area HP 2020-MHMD.

Eligibility

Eligible applicants are domestic public and private nonprofit entities.  For example:

  • Public or private universities and colleges
  • Guild and/or professional organizations
  • National stakeholder groups
Award Information
Funding Mechanism: 
Grant
Anticipated Total Available Funding: 
$2,900,000
Anticipated Number of Awards: 
One Award
Anticipated Award Amount: 
Up to $2,900,000 per year
Length of Project: 
Up to 5 years
Cost Sharing/Match Required?: 
No

Proposed budgets cannot exceed $2,900,000 in total costs (direct and indirect) in any year of the proposed project.  Annual continuation awards will depend on the availability of funds, grantee progress in meeting project goals and objectives, timely submission of required data and reports, and compliance with all terms and conditions of award.

Funding estimates for this announcement are based on an annualized Continuing Resolution and do not reflect the final FY 2018 appropriation.  Applicants should be aware that funding amounts are subject to the availability of funds.  

Contact Information
Program Issues

Tracie Pogue
Office of Policy, Planning and Innovation
Substance Abuse and Mental Health Services Administration
(240) 276-0105
Tracie.pogue@samhsa.hhs.gov

Grants Management and Budget Issues

Gwendolyn Simpson
Office of Financial Resources, Division of Grants Management
Substance Abuse and Mental Health Services Administration
(240) 276-1408
FOACMHS@samhsa.hhs.gov

Last Updated: 01/17/2018